Please login to the form below

Not currently logged in
Email:
Password:

Immatics

This page shows the latest Immatics news and features for those working in and with pharma, biotech and healthcare.

Celgene boosts IO presence with Immatics deal

Celgene boosts IO presence with Immatics deal

Immatics’ XPRESIDENT technology and XCEPTOR TCR discovery and engineering platform are tailored to developing effective TCR-T cell therapies. ... Celgene will also be able to manufacture and gain worldwide commercialisation rights to the TCR-T cell

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2017 Deal Watch January 2017

    was Amgen with the purchase of Immatics' next-generation, T-cell engaging bispecific immunotherapies. ... Immatics. Amgen. Licence /  joint development. Next-generation, T-cell engaging bispecific immuno-therapies .

  • Deal Watch table for November 2013 Deal Watch table for November 2013

    hyperactivity disorder, pain, urology and allergy. 1, 600. immatics / Roche.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Peter Chambre joins cancer vaccine biotech Immatics Peter Chambre joins cancer vaccine biotech Immatics

    Paul Higham, CEO of Immatics, said: “I am delighted to welcome Peter as our new chairman. ... He said: “Immatics' vaccines, based on the company's highly rational approach to cancer vaccine discovery, have already demonstrated very promising results

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Language barriers: Obesity has become a loaded word
...
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....

Infographics